Affimed Says FDA Grants Fast Track Designation For AFM13 With AlloNK To Treat R/r Hodgkin Lymphoma

RTTNews | 697天前
Affimed Says FDA Grants Fast Track Designation For AFM13 With AlloNK To Treat R/r Hodgkin Lymphoma

(RTTNews) - Immuno-oncology company Affimed N.V. (AFMD) announced that the FDA has granted fast track designation to the combination of its innate cell engager (ICE) AFM13 with AlloNK for the potential treatment of relapsed/refractory (r/r) Hodgkin lymphoma (HL).

The combination treatment is entering Phase 2 development and will be investigated in Affimed's LuminICE-203 study (NCT05883449), which received IND-clearance earlier this year. The study also includes an exploratory cohort of CD30-positive peripheral T-cell lymphoma patients.

The FDA's decision is based on available data showing the potential of the AFM13 and AlloNK combination therapy to overcome current limitations in the treatment of r/r HL.

LuminICE-203 builds on the clinical findings from the phase 1/2 AFM13-104 trial (NCT04074746), in which investigators assessed AFM13 in combination with cord blood-derived natural killer cells in heavily pretreated patients with CD30-positive Hodgkin lymphoma and non-Hodgkin lymphoma.

Data presented to date from this trial have shown outstanding clinical results in late-stage, multi-refractory, patients with a 94% overall response rate (ORR), a 71% complete response (CR) rate and a well-managed safety profile at the recommended phase 2 dose (RP2D).

read more
Swiss Market Ends Marginally Up

Swiss Market Ends Marginally Up

The Switzerland market ended marginally up on Friday despite exhibiting weakness for much of the time past noon. Investors continued to react to earnings and assess the economic impact of reciprocal tariffs, and stayed largely cautious with their moves. A report showing a drop in Swiss consumer confidence in the month of July hurt sentiment.
RTTNews | 21小时19分钟前
Major European Markets Close On Mixed Note

Major European Markets Close On Mixed Note

Major European markets turned in a mixed performance on Friday with investors largely staying cautious, assessing the impact of tariffs on global economic growth, and continuing to digest corporate earnings announcements and other data.
RTTNews | 21小时44分钟前
Positive Start Seen For Canadian Stocks

Positive Start Seen For Canadian Stocks

Canadian stocks may edge up a bit in early trades Friday morning with some encouraging earnings announcements and firm commodity prices aiding sentiment. Investors will also be reacting to the data showing a 41,000 jobs drop in Canadian employment in the month of July. Data from Statistics Canada also showed that the unemployment rate in Canada came in unchanged at 6.9%.
RTTNews | 1天前
UK Market Roughly Flat; Mining Stocks Move Higher

UK Market Roughly Flat; Mining Stocks Move Higher

Amid a lack of economic and earnings data, U.K. stocks are moving in a tight range in somewhat lackluster trade on Friday. Investors are assessing the potential impact of the Trump administration's reciprocal tariffs on global economic growth. Optimism about a rate cut by the Fed next month is aiding sentiment a bit.
RTTNews | 1天前
CAC 40 Climbs Higher For 3rd Straight Day

CAC 40 Climbs Higher For 3rd Straight Day

French stocks are modestly higher on Friday, extending gains to a third straight session, with mostly encouraging corporate earnings announcements aiding sentiment. Concerns about the potential impact of Trump's reciprocal tariffs limit market's upside a bit.
RTTNews | 1天前